Aurobindo Pharma receives USFDA approval for Acetaminophen Injection

Aurobindo Pharma receives USFDA approval for Acetaminophen Injection

by admin- Thursday, October 22nd, 2020 04:18:57 PM

Aurobindo Pharma received final approval from the USA Food & Drug Administration (USFDA) to fabricate and market Acetaminophen Injection, 1,000 mg/ 100 mL unmarried-dose vial (SDV). Aurobindo’s Acetaminophen Injection is a commonplace equivalent of Mallinckrodt’s Ofirmev Injection. The product could be released in December 2020.

News Updates